Metrogyl DG Gel

Metronidazole, a nitroimidazole antibiotic, provides targeted action against anaerobic bacteria and protozoa by inhibiting nucleic acid synthesis, thereby reducing infection and inflammation. The synergistic effect of these two active ingredients makes Metrogyl DG Gel particularly useful in treating gingivitis, periodontitis, dental plaque, and other localized infections where anaerobic bacteria predominate.

The gel formulation allows for localized application, ensuring high concentration at the site of infection with minimal systemic absorption, thus reducing the risk of systemic side effects. Metrogyl DG Gel is indicated for use in dental practice for pre- and post-operative care, as well as in dermatological conditions involving bacterial colonization. It should be used as directed by a healthcare professional, avoiding contact with eyes and mucous membranes other than the intended site of application.

Regular use as prescribed enhances therapeutic outcomes and supports oral and skin health.